Your session is about to expire
← Back to Search
6% aqueous phenol for Osteoarthritis
Study Summary
This trial is testing whether a nerve-blocking procedure using phenol helps relieve knee pain from osteoarthritis better than a placebo procedure.
- Osteoarthritis
- Chronic Knee Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Frequently Asked Questions
Does the FDA recognize 6% aqueous phenol as safe for use?
"Evidence from this Phase 4 trial led to our team at Power assigning 6% aqueous phenol with the highest safety rating of 3."
Are there any available opportunities to participate in this trial?
"The information on clinicaltrials.gov indicates that this medical trial is accepting new participants. This study was initially unveiled on November 1st 2021, and its parameters were most recently revised at the end of March 2022."
How many subjects are involved in the current clinical trial?
"Affirmative. Clinicaltrials.gov hosts details that indicate this clinical trial is actively seeking participants, with the first posting being recorded on November 1st 2021 and most recent update posted on March 30th 2022. This study demands a total of 30 subjects at one medical centre to be enrolled in order to complete recruitment goals."
To what ailments has 6% aqueous phenol been applied as a remedy?
"By using 6% aqueous phenol, individuals can address throat irritation, ringworm, and psoriasis."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger